Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias.
about
Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic SyndromesIron chelation therapy in myelodysplastic syndromes: where do we stand?Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO studyAssessment of cardiac iron by MRI susceptometry and R2* in patients with thalassemiaLiver iron content determination by magnetic resonance imaging.Iron chelation therapy in myelodysplastic syndromes.Optimal method for early detection of cardiac disorders in thalassemia major patients: magnetic resonance imaging or echocardiography?The search for better prognostic models in myelodysplastic syndromesAssociation of iron overload based quantitative T2* MRI technique and carotid intima-media thickness in patients with beta-thalassemia: a cross-sectional study.Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndromeMRI T2* imaging for assessment of liver iron overload: study of different data analysis approaches.Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging.Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndromeDeferasirox treatment of iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndromes in medical practice: results from the observational studies eXtend and eXjange.Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.Evaluation of myocardial iron overload using magnetic resonance imaging.The treatment of secondary hemochromatosis.Myelodysplastic Syndromes and Iron Chelation TherapyOptimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.Iron overload and allogeneic hematopoietic stem-cell transplantation.The relevance of iron overload and the appropriateness of iron chelation therapy for patients with myelodysplastic syndromes: a dialogue and debate.MRI of cardiac iron overload.Review of therapeutic options and the management of patients with myelodysplastic syndromes.Early detection of cardiac involvement in thalassemia: From bench to bedside perspective.Toward resolving the unsettled role of iron chelation therapy in myelodysplastic syndromes.An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanisms.Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study).Iron chelation therapy in low risk myelodysplastic syndrome.Myocardial and liver iron overload, assessed using T2* magnetic resonance imaging with an excel spreadsheet for post processing in Tunisian thalassemia major patients.Value of severe liver iron overload for assessing heart iron levels in thalassemia major patients.The relationship between cardiac and liver iron evaluated by MR imaging in haematological malignancies and chronic liver disease.Iron overload in patients undergoing hematopoietic stem cell transplantation.Polystyrene microsphere-ferritin conjugates: a robust phantom for correlation of relaxivity and size distribution.Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial).Early cardiac iron overload in children with transfusion-dependent anemias.Effect of deferasirox chelation on liver iron and total body iron concentration.Prevalence and distribution of iron overload in patients with transfusion-dependent anemias differs across geographic regions: results from the CORDELIA study.Influence of the analysis technique on estimating hepatic iron content using MRI.An assessment of iron overload in children treated for cancer and nonmalignant hematologic disorders.Transfusion intensity, not the cumulative red blood cell transfusion burden, determines the prognosis of patients with myelodysplastic syndrome on chronic transfusion support.
P2860
Q26748281-9F03E878-78C0-4100-8113-D1493235CD9FQ27011747-ED424FD1-07EB-48C4-893A-1ED743C199A4Q33707461-352AA807-0022-4566-9C5A-29FB1D5EFC5AQ33729649-CDA1461B-99D5-4141-BCFE-8753093BA513Q33764777-EBF31E07-52D7-40AE-90EC-5BEAF17BA9C2Q34002840-5F071E9A-E898-4AF7-9ADE-D3CA5B970EF4Q34302477-8B4A5DC7-C085-4A71-AF9F-3877A5D66D9CQ34386812-3790FE33-FFCE-4F6A-8090-275200195D5FQ34499633-A24B5AE5-618E-4FD3-B506-D63798BC710FQ35743810-1A85B7DE-E163-4E3D-A821-114BF647ED78Q35918898-AC92D7B8-64BF-4539-9563-C74910D8CBAFQ36285290-DDB0A436-D966-4326-806F-AC41D7628977Q36296712-CFBDBC4F-A4FE-42FC-9CEE-B1AF95427F94Q36420464-C9070A35-0BF7-46F2-8635-FC3E7901D235Q37263146-944EFB0C-2871-4F93-9700-6AAEC5458235Q37573422-B27A18E9-E15B-458C-9051-281C04C96B16Q37591211-51FD3800-C4B9-4EC6-B9F5-47DC28EA08B1Q37677229-E83B9E16-94A4-432A-A056-BDAD9C5D8D91Q37833060-614E5391-D088-43BB-933B-E9B10102EAF6Q37842351-A4CF8F55-FF3B-4F75-A34E-FF34CB9DF42AQ37849630-3283A481-C4FD-44AC-89B0-9A9B287139EFQ38054638-04D36827-3114-4097-9B5C-8BA213657B64Q38095121-B4E3D552-BE17-489A-9A93-2E2EB21A3DDFQ38134738-5FCB0F60-91EA-4C49-AFAB-DD199DD4E67CQ38196963-90B20549-7A20-430C-8E15-1059FF7F67FEQ38368123-5DC7BEED-EB20-4521-A63B-2BF14C4E70A7Q38388734-B6B606A5-A231-4D97-B2D7-3718EBD3363AQ38903926-55BBD8EB-53D1-41BD-BA26-CF8EFD0891B0Q39300721-A524F76C-0C85-4B12-8052-0BBB13777B00Q39869729-CBDD3F5C-7F72-4F3B-8278-C4D310AE5EC0Q40787079-86C38C23-9715-490C-8CF5-514E1EB45757Q41914835-59941EBD-D989-47B8-AA2E-7A5909049A9DQ42018783-BE034AAE-CD66-4718-B3C0-6BFEEF5828CCQ42645802-7191D897-ABEA-4084-AFD8-395613F59BF1Q42956267-128E9484-2807-45CE-B645-48B2DA3DE2DFQ45392161-A53B71B0-C52D-48EB-9125-A4A081BD8B77Q46700826-4A5E3387-C36D-4BE8-924D-6FA092369592Q46728010-3875DD8B-09CE-4907-B4E2-1FBA7B409F44Q50476105-A6F518EC-5971-4F41-8D63-9304F69F46D5Q50545368-CC5DF524-073C-44B7-ABB0-15D5306E5AFF
P2860
Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Myocardial iron overload asses ...... atients with acquired anemias.
@en
Myocardial iron overload asses ...... atients with acquired anemias.
@nl
type
label
Myocardial iron overload asses ...... atients with acquired anemias.
@en
Myocardial iron overload asses ...... atients with acquired anemias.
@nl
prefLabel
Myocardial iron overload asses ...... atients with acquired anemias.
@en
Myocardial iron overload asses ...... atients with acquired anemias.
@nl
P2093
P356
P1433
P1476
Myocardial iron overload asses ...... atients with acquired anemias.
@en
P2093
Anna Angela Di Tucci
Annalisa Agus
Attilio Gabbas
Cristina Depau
Daniele Derudas
Gildo Matta
Simona Deplano
P304
P356
10.3324/HAEMATOL.12759
P577
2008-07-04T00:00:00Z